Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on April 6, 2020, covering events occurring on April 2, 2020. The Company is a Delaware corporation with its principal executive offices in Lexington, MA, and its common stock trades on The NASDAQ Stock Market under the symbol "PULM".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report addresses corporate governance matters rather than financial performance.
Material Changes
The Board of Directors established June 17, 2020, as the date for the 2020 Annual Meeting of Stockholders. This date represents a change of more than 30 days from the anniversary of the 2019 Annual Meeting. Consequently, the Company set April 20, 2020, as the record date for the Annual Meeting.
Guidance, Outlook, and Governance Deadlines
In accordance with Rule 14a-5(f) and Rule 14a-8(e) under the Exchange Act and the Company's bylaws, the deadline for receipt of stockholder proposals or nominations for inclusion in the proxy statement is 5:00 p.m., Eastern Time, on April 20, 2020. Proposals must comply with all applicable SEC rules and the Company's amended and restated bylaws.
Key Facts for Investor Verification
- Annual Meeting Date: June 17, 2020.
- Record Date: April 20, 2020.
- Proposal Deadline: April 20, 2020, at 5:00 p.m. Eastern Time.
- Reason for Filing: Notification of the changed meeting date requiring a new deadline for shareholder proposals under Rule 14a-8.